Biotech analyst Brian Skorney and longtime biotech executive Daphne Zohar joined this week’s episode of “The Readout LOUD” to discuss how a new Trump administration may affect the Food and Drug Administration, the biotech industry, and stocks. Below are highlights from their conversation with hosts Elaine Chen, Adam Feuerstein, and Allison DeAngelis.
The following transcript of the conversation has been lightly edited for length and clarity.
You can listen to the full episode here.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
View All Plans
